CaixaBank, S.A.’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
Other funds holding PBE
CaixaBank, S.A.'s PBE Position: Q1 2017 in Review
CaixaBank, S.A. sold out of Invesco Biotechnology & Genome ETF (PBE) in Q1 2017, closing a stake of 450 shares — an estimated $17.5K sold.
CaixaBank, S.A. first reported a position in PBE in Q4 2016 and held it in 1 quarter. The position peaked at $17.5K in Q4 2016. 68 funds tracked by Wall St. Rank hold PBE as of Q1 2017.
- CaixaBank, S.A. reported no remaining Invesco Biotechnology & Genome ETF position as of Q1 2017 after selling out during the quarter.
- CaixaBank, S.A. sold 450 Invesco Biotechnology & Genome ETF shares in Q1 2017, an estimated $17.5K.
- CaixaBank, S.A. first reported a position in Invesco Biotechnology & Genome ETF in Q4 2016 and held it in 1 quarter.
- CaixaBank, S.A.'s Invesco Biotechnology & Genome ETF position peaked at $17.5K in Q4 2016.
- 68 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q1 2017.
Based on CaixaBank, S.A.'s 13F filing for Q1 2017, filed 16 Nov 2026.